Cardiac surgery in cirrhotic patients: results and evaluation of risk factors.

Liver cirrhosis increases mortality and morbidity following cardiac surgery. This study evaluated the results of cardiac surgery in cirrhotic patients and the relevance of EuroSCORE, Child-Turcotte-Pugh (CTP) class and model for end-stage liver disease (MELD) score in terms of prediction of surgical mortality and survival.
The study involved 34 patients with hepatic cirrhosis who underwent cardiac surgery between January 1996 and January 2010.
The in-hospital mortality was 26%. Postoperative mortality of patients with CTP class A, B or C was 18, 40 and 100%, respectively. In univariate analysis, a history of cerebrovascular disease and hypoalbuminaemia was predictive of operative mortality. Multivariate exact logistic regression revealed that hypoalbuminaemia was an independent factor. Long-term survival was 63 ± 0.08% at 1 year and 40.2 ± 0.12% at 5 years. The 1-year survival for CTP A, B and C was 76.7 ± 0.09, 60 ± 15.4 and 0%, respectively, and the 5-year survival was 60 ± 15.4, 25 ± 0.19 and 0%, respectively. The EuroSCORE was not a discriminant [area under the curve (AUC): 0.57 ± 0.15]. The performance of CTP class and MELD score was better, but neither provided optimal discrimination: AUC was 0.691 ± 0.110 for MELD and 0.658 ± 0.10 for CTP class.
Cardiac surgery can be performed safely in CTP class A patients. In CTP C patients, surgery is hazardous, and an alternative treatment must be considered. In CTP B, the MELD score could be helpful in deciding whether surgical intervention is a reasonable option.
AuthorsFabrice Vanhuyse, Pablo Maureira, Eric Portocarrero, Nicolas Laurent, Malik Lekehal, Jean-Pierre Carteaux, Jean-Pierre Villemot
JournalEuropean journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery (Eur J Cardiothorac Surg) Vol. 42 Issue 2 Pg. 293-9 (Aug 2012) ISSN: 1873-734X [Electronic] Germany
PMID22290926 (Publication Type: Journal Article)
  • Aged
  • Blood Loss, Surgical (statistics & numerical data)
  • Blood Transfusion (statistics & numerical data)
  • Cardiac Surgical Procedures (mortality)
  • Epidemiologic Methods
  • Female
  • Humans
  • Liver Cirrhosis (complications, mortality)
  • Male
  • Postoperative Complications (mortality)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: